SINTX Technologies Shares Q3 2021 Revenue Update
October 14 2021 - 9:00AM
SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or
the “Company”), an original equipment manufacturer of advanced
ceramics, announced today preliminary Q3 2021 revenue results and
expectation of new Q4 2021 revenue from open orders of advanced
ceramics prototypes.
Estimated revenue in Q3 2021 was approximately
$240k which is more than the revenue in each of Q1 and Q2 2021.
Revenue came from three business areas, including monolithic
silicon nitride for spinal implants and SN-PEEK for spinal
implants, silicon nitride powder for an antipathogenic fabric
application, and boron carbide torso plates for armor.
SINTX anticipates new revenue sources in Q4 with
several open prototype orders we expect to fill with advanced
silicon nitride for separate aerospace engine and rocket
components, FleX SN powder for antipathogenic fabric, and an
industrial boron carbide application.
SINTX continues to expand and gain momentum
within the key areas of its business and looks forward to providing
a business update following the release of the Quarterly Report on
Form 10-Q for Q3 2021.
About SINTX Technologies,
Inc.
SINTX Technologies is an OEM ceramics company
that develops and commercializes advanced ceramics for medical and
non-medical applications. The core strength of SINTX Technologies
is the manufacturing, research, and development of ceramics for
external partners. The Company presently manufactures silicon
nitride powders and components in its FDA registered, ISO
13485:2016 certified, and ASD9100D certified manufacturing
facility.
For more information on SINTX Technologies
or its silicon nitride material platform, please
visit www.sintx.com.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 (PSLRA) that are subject to a number of risks
and uncertainties. Risks and uncertainties that may cause such
differences include, among other things: our products may not prove
to be as effective as other products currently being commercialized
or to be commercialized in the future by competitors; risks
inherent in manufacturing and scaling up to commercial quantities
while maintaining quality controls; volatility in the price of
SINTX’s common stock; the uncertainties inherent in new product
development, including the cost and time required to commercialize
such product(s); market acceptance of our products once
commercialized; SINTX’s ability to raise funding and other
competitive developments. Readers are cautioned not to place undue
reliance on the forward-looking statements, which speak only as of
the date on which they are made and reflect management’s current
estimates, projections, expectations and beliefs. There can be no
assurance that any of the anticipated results will occur on a
timely basis or at all due to certain risks and uncertainties, a
discussion of which can be found in SINTX’s Risk Factors disclosure
in its Annual Report on Form 10-K, filed with the Securities and
Exchange Commission (SEC) on March 22, 2021, and in SINTX’s other
filings with the SEC. SINTX disclaims any obligation to update any
forward-looking statements. SINTX undertakes no obligation to
publicly revise or update the forward-looking statements to reflect
events or circumstances that arise after the date of this
report.
Business Inquiries for
SINTX:SINTX Technologies801.839.3502IR@sintx.com
Media Inquiries for SINTX:
Amanda Barry Director of Content & PR The Summit Group
abarry@summitslc.com
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Mar 2024 to Apr 2024
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Apr 2023 to Apr 2024